Company / R&D Expense
Alphatec Holdings, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$76.3M
FY2025
5-year range
$32.0M / $80.7M
FY2021-FY2025
Trend
-5.5%
vs FY2024
Sector context
#67 of 110
Health Care
What the data says
At $76M, Alphatec Holdings, Inc.'s r&d expense ranks #67 of 110 in the Health Care sector. Improved from $70M to $76M over the past 2 years.
Based on SEC 10-K filings.
$76M in FY2025 with a 5-year CAGR of +32.4%.
Improved from $70M to $76M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +20.1%
- 5-Year CAGR
- +32.4%
- 10-Year CAGR
- -
Sector benchmark
#67 of 110 in Health CareTop 61% of 110This company $76.3M Sector average $298.2M
▼
-74.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.4%, indicating consistent growth.
- In FY2025, r&d expense decreased 5.5% year-over-year.
- Ranks #67 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $76.3M | -5.5% |
| FY2024 | $80.7M | +15.1% |
| FY2023 | $70.1M | +59.2% |
| FY2022 | $44.0M | +37.5% |
| FY2021 | $32.0M | +70.8% |
| FY2020 | $18.7M | +35.4% |
| FY2019 | $13.8M | +40.6% |
| FY2018 | $9.9M | +100.3% |
| FY2017 | $4.9M | -46.8% |
| FY2016 | $9.2M | -47.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026